browse the database add your fund

focal's founder newsletter:

VC Database/Atlas Venture

← back to database

Atlas Venture

HQ · Massachusetts

Website LinkedIn Crunchbase Update entry

Atlas Venture creates and finances breakthrough biotechnology companies, working alongside scientific founders and experienced operators from company formation through clinical development. The firm commonly leads company formation, Seed and Series A financings and raised $450M for Fund XIV in 2026.

Stage focus

SeedSeries A

Lead / follow

Mostly Lead

Ownership target

7-10%

Specialization

Life Sciences

Generalist / Specialist

Specialist

Latest fund size

$450M Fund XIV

Latest fund vintage

2026

Investing team

Aimee RaleighPrincipal
Bruce BoothPartner
David GrayzelPartner
Jason RhodesPartner
Jean-Francois FormelaPartner
Jernej GodecPrincipal
Julia PianSenior Associate
Justin FengSenior Associate
Kevin BittermanPartner
Maurizio FazioPrincipal
Michael GladstonePartner
Stella PaffenholzSenior Associate

How to reach them

lifesciences@atlasventure.com

Notable investments

Alnylam Pharmaceuticals, Exelixis, Intellia Therapeutics, Kymera Therapeutics, Dyne Therapeutics, Disc Medicine, Replimune, Cogent Biosciences

Sources

atlasventure.com ↗atlasventure.com/team ↗atlasventure.com/portfolio ↗atlasventure.com/2024/12/05/atlas-venture-announces-450-million-fund-xiv ↗

Spotted an error on this profile?

Similar firms

DimensionPre-Seed / Inception · Seed · $3M - $10Mview profile →Good Growth CapitalPre-Seed / Inception · Seed · $250-500kview profile →Seae VenturesSeed · Series A · $1-3mview profile →

Atland Ventures Atman

Explore related VC lists

Life Sciences specialist VCs All VC lists

findfunding.vc · an open source database by focal

lists:pre-seed seed series a series b all·add your fund linkedin open data llms.txt

Atlas Venture — early-stage investor profile | findfunding.vc